Barclays Upgrades Mindray Medical (MR) to Overweight

Article Stock Quotes (1) Comments (0)

Earlier, Barclays upgraded Mindray Medical (NYSE: MR) from Equalweight to Overweight with a price target of $42.00.

For an analyst ratings summary and ratings history on Mindray Medical click here. For more ratings news on Mindray Medical click here.

Shares of Mindray Medical closed at $34.96 yesterday, with a 52 week range of $21.25-$36.08.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: BofA/Merrill Lynch Upgrades Adobe (ADBE) to Buy
• Howard Weil Upgrades Linn Co, LLC (LNCO) to Outperform
• Goldman Sachs Upgrades Enbridge (ENB) to Conviction Buy

Create E-mail Alert Related Categories

Upgrades

Related Entities

Barclays

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?